Tat Seng Packaging Group Ltd (SGX:T12)

Market Cap	141.48M
Revenue (ttm)	253.94M
Net Income (ttm)	18.83M
Shares Out	157.20M
EPS (ttm)	0.12
PE Ratio	7.52
Forward PE	n/a
Dividend	0.06 (6.67%)
Ex-Dividend Date	May 15, 2025

Volume	36,500
Average Volume	24,460
Open	0.9000
Previous Close	0.9300
Day's Range	0.9000 - 0.9000
52-Week Range	0.7250 - 1.0000
Beta	0.37
RSI	43.45
Earnings Date	Aug 11, 2025

About Checkpoint Therapeutics

Tat Seng Packaging Group Ltd, together with its subsidiaries, designs, manufactures, and sells corrugated paper products and other packaging products in Singapore and the People's Republic of China. The company offers regular slotted carton boxes, die-cut carton boxes, offset-printed boxes, corrugated partition pads/layer pads, corrugated boards, and heavy duty corrugated products; other packaging-related or customized products, such as tapes, stretch films, foams, and edgeboard protectors; and paper pallets for storage and transport requiremen...

• Industry: Paperboard Containers And Boxes
• Founded: 1968
• Employees: 363
• Stock Exchange: Singapore Exchange
• Ticker Symbol: T12

Financial Performance

In 2024, Tat Seng Packaging Group's revenue was 253.94 million, a decrease of -1.90% compared to the previous year's 258.87 million. Earnings were 18.83 million, a decrease of -0.10%.